ID   IL18R_HUMAN             Reviewed;         541 AA.
AC   Q13478; B2R9Y5; Q52LC9;
DT   06-DEC-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   07-APR-2021, entry version 179.
DE   RecName: Full=Interleukin-18 receptor 1;
DE            Short=IL-18R-1;
DE            Short=IL-18R1;
DE            EC=3.2.2.6 {ECO:0000255|PROSITE-ProRule:PRU00204};
DE   AltName: Full=CD218 antigen-like family member A;
DE   AltName: Full=CDw218a;
DE   AltName: Full=IL1 receptor-related protein;
DE            Short=IL-1Rrp;
DE            Short=IL1R-rp;
DE   AltName: Full=Interleukin-18 receptor alpha {ECO:0000303|PubMed:10653850, ECO:0000303|PubMed:14528293, ECO:0000303|PubMed:25261253, ECO:0000303|PubMed:25500532};
DE            Short=IL-18R-alpha;
DE            Short=IL-18Ralpha {ECO:0000303|PubMed:10653850, ECO:0000303|PubMed:14528293, ECO:0000303|PubMed:25261253, ECO:0000303|PubMed:25500532};
DE   AltName: CD_antigen=CD218a;
DE   Flags: Precursor;
GN   Name=IL18R1 {ECO:0000312|HGNC:HGNC:5988}; Synonyms=IL1RRP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANT ALA-317 DEL, LACK OF BINDING TO IL1A
RP   AND IL1B, TISSUE SPECIFICITY, AND FUNCTION.
RX   PubMed=8626725; DOI=10.1074/jbc.271.8.3967;
RA   Parnet P., Garka K.E., Bonnert T.P., Dower S.K., Sims J.E.;
RT   "IL-1Rrp is a novel receptor-like molecule similar to the type I
RT   interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP.";
RL   J. Biol. Chem. 271:3967-3970(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 19-29; 55-58; 59-71; 211-221; 222-231; 269-275;
RP   276-280; 319-315 AND 524-535, AND CHARACTERIZATION.
RX   PubMed=9325300; DOI=10.1074/jbc.272.41.25737;
RA   Torigoe K., Ushio S., Okura T., Kobayashi S., Taniai M., Kunikata T.,
RA   Murakami T., Sanou O., Kojima H., Fujii M., Ohta T., Ikeda M., Ikegami H.,
RA   Kurimoto M.;
RT   "Purification and characterization of the human interleukin-18 receptor.";
RL   J. Biol. Chem. 272:25737-25742(1997).
RN   [6]
RP   FUNCTION, TISSUE SPECIFICITY, AND INDUCTION BY IL12/INTERLEUKIN-12.
RX   PubMed=10653850; DOI=10.1093/intimm/12.2.151;
RA   Tominaga K., Yoshimoto T., Torigoe K., Kurimoto M., Matsui K., Hada T.,
RA   Okamura H., Nakanishi K.;
RT   "IL-12 synergizes with IL-18 or IL-1beta for IFN-gamma production from
RT   human T cells.";
RL   Int. Immunol. 12:151-160(2000).
RN   [7]
RP   TISSUE SPECIFICITY, AND INDUCTION BY IL12/INTERLEUKIN-12.
RX   PubMed=10925275; DOI=10.4049/jimmunol.165.4.1933;
RA   Sareneva T., Julkunen I., Matikainen S.;
RT   "IFN-alpha and IL-12 induce IL-18 receptor gene expression in human NK and
RT   T cells.";
RL   J. Immunol. 165:1933-1938(2000).
RN   [8]
RP   TISSUE SPECIFICITY.
RX   PubMed=11046021; DOI=10.4049/jimmunol.165.9.4950;
RA   Debets R., Timans J.C., Churakowa T., Zurawski S., de Waal Malefyt R.,
RA   Moore K.W., Abrams J.S., O'Garra A., Bazan J.F., Kastelein R.A.;
RT   "IL-18 receptors, their role in ligand binding and function: anti-IL-1RAcPL
RT   antibody, a potent antagonist of IL-18.";
RL   J. Immunol. 165:4950-4956(2000).
RN   [9]
RP   SUBUNIT, SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=14528293; DOI=10.1038/nsb993;
RA   Kato Z., Jee J., Shikano H., Mishima M., Ohki I., Ohnishi H., Li A.,
RA   Hashimoto K., Matsukuma E., Omoya K., Yamamoto Y., Yoneda T., Hara T.,
RA   Kondo N., Shirakawa M.;
RT   "The structure and binding mode of interleukin-18.";
RL   Nat. Struct. Biol. 10:966-971(2003).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) OF 19-329, GLYCOSYLATION AT ASN-197;
RP   ASN-203; ASN-236 AND ASN-297, DISULFIDE BONDS, AND FUNCTION.
RX   PubMed=25261253; DOI=10.1016/j.febslet.2014.09.019;
RA   Wei H., Wang D., Qian Y., Liu X., Fan S., Yin H.S., Wang X.;
RT   "Structural basis for the specific recognition of IL-18 by its alpha
RT   receptor.";
RL   FEBS Lett. 588:3838-3843(2014).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (3.10 ANGSTROMS) OF 20-329, GLYCOSYLATION AT ASN-91;
RP   ASN-102; ASN-150; ASN-197; ASN-203; ASN-236 AND ASN-297, DISULFIDE BONDS,
RP   MUTAGENESIS OF ASN-297, SUBUNIT, SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=25500532; DOI=10.1038/ncomms6340;
RA   Tsutsumi N., Kimura T., Arita K., Ariyoshi M., Ohnishi H., Yamamoto T.,
RA   Zuo X., Maenaka K., Park E.Y., Kondo N., Shirakawa M., Tochio H., Kato Z.;
RT   "The structural basis for receptor recognition of human interleukin-18.";
RL   Nat. Commun. 5:5340-5340(2014).
CC   -!- FUNCTION: Within the IL18 receptor complex, responsible for the binding
CC       of the proinflammatory cytokine IL18, but not IL1A nor IL1B
CC       (PubMed:8626725, PubMed:14528293, PubMed:25261253, PubMed:25500532).
CC       Involved in IL18-mediated IFNG synthesis from T-helper 1 (Th1) cells
CC       (PubMed:10653850). Contributes to IL18-induced cytokine production,
CC       either independently of SLC12A3, or as a complex with SLC12A3 (By
CC       similarity). {ECO:0000250|UniProtKB:Q61098,
CC       ECO:0000269|PubMed:10653850, ECO:0000269|PubMed:14528293,
CC       ECO:0000269|PubMed:25261253, ECO:0000269|PubMed:25500532,
CC       ECO:0000269|PubMed:8626725}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide;
CC         Xref=Rhea:RHEA:16301, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17154, ChEBI:CHEBI:57540, ChEBI:CHEBI:57967; EC=3.2.2.6;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00204};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16302;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00204};
CC   -!- SUBUNIT: Forms a ternary complex with IL18 and IL18RAP
CC       (PubMed:14528293, PubMed:25500532). Within this complex, IL18R1 is
CC       involved in ligand-binding and IL18RAP in signaling leading to NF-
CC       kappa-B and JNK activation (Probable). Interacts with SLC12A3 in
CC       peritoneal macrophages; this interaction is increased by IL18 treatment
CC       (By similarity). {ECO:0000250|UniProtKB:Q61098,
CC       ECO:0000269|PubMed:14528293, ECO:0000269|PubMed:25500532, ECO:0000305}.
CC   -!- INTERACTION:
CC       Q13478; Q14116: IL18; NbExp=2; IntAct=EBI-9817499, EBI-3910835;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:14528293}; Single-
CC       pass type I membrane protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in leukocytes, spleen, lung. Also
CC       expressed, but at lower levels, in liver, small intestine, colon,
CC       prostate, thymus, placenta, and heart. Specifically coexpressed with
CC       IL18R1 in Th1 cells (PubMed:10925275, PubMed:11046021,
CC       PubMed:10653850). {ECO:0000269|PubMed:10653850,
CC       ECO:0000269|PubMed:10925275, ECO:0000269|PubMed:11046021,
CC       ECO:0000269|PubMed:8626725}.
CC   -!- INDUCTION: Induced by IL12/interleukin-12 in T-cells. Proposed to be a
CC       phenotypic marker for T-helper 1 (Th1) cells.
CC       {ECO:0000269|PubMed:10653850, ECO:0000269|PubMed:10925275}.
CC   -!- DOMAIN: The TIR domain mediates NAD(+) hydrolase (NADase) activity.
CC       Self-association of TIR domains is required for NADase activity.
CC       {ECO:0000255|PROSITE-ProRule:PRU00204}.
CC   -!- PTM: N-glycosylated. N-linked glycosyl chains contribute to ligand
CC       recognition and intra-receptor interactions required for formation of
CC       an active ternary receptor complex. {ECO:0000269|PubMed:25261253,
CC       ECO:0000269|PubMed:25500532}.
CC   -!- SIMILARITY: Belongs to the interleukin-1 receptor family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U43672; AAC50390.1; -; mRNA.
DR   EMBL; AK313967; BAG36682.1; -; mRNA.
DR   EMBL; AC007248; AAY15048.1; -; Genomic_DNA.
DR   EMBL; BC069575; AAH69575.1; -; mRNA.
DR   EMBL; BC093975; AAH93975.1; -; mRNA.
DR   EMBL; BC093977; AAH93977.1; -; mRNA.
DR   CCDS; CCDS2060.1; -.
DR   RefSeq; NP_001269328.1; NM_001282399.1.
DR   RefSeq; NP_003846.1; NM_003855.3.
DR   PDB; 3WO3; X-ray; 3.10 A; B/D/F/H/J/L=20-329.
DR   PDB; 3WO4; X-ray; 3.10 A; B=20-329.
DR   PDB; 4R6U; X-ray; 2.80 A; A/C=19-329.
DR   PDBsum; 3WO3; -.
DR   PDBsum; 3WO4; -.
DR   PDBsum; 4R6U; -.
DR   SASBDB; Q13478; -.
DR   SMR; Q13478; -.
DR   BioGRID; 114337; 5.
DR   IntAct; Q13478; 3.
DR   MINT; Q13478; -.
DR   STRING; 9606.ENSP00000387211; -.
DR   GlyGen; Q13478; 8 sites.
DR   iPTMnet; Q13478; -.
DR   PhosphoSitePlus; Q13478; -.
DR   BioMuta; IL18R1; -.
DR   EPD; Q13478; -.
DR   jPOST; Q13478; -.
DR   MassIVE; Q13478; -.
DR   MaxQB; Q13478; -.
DR   PaxDb; Q13478; -.
DR   PeptideAtlas; Q13478; -.
DR   PRIDE; Q13478; -.
DR   ProteomicsDB; 59476; -.
DR   ABCD; Q13478; 1 sequenced antibody.
DR   Antibodypedia; 2363; 833 antibodies.
DR   Ensembl; ENST00000233957; ENSP00000233957; ENSG00000115604.
DR   Ensembl; ENST00000409599; ENSP00000387211; ENSG00000115604.
DR   Ensembl; ENST00000410040; ENSP00000386663; ENSG00000115604.
DR   GeneID; 8809; -.
DR   KEGG; hsa:8809; -.
DR   UCSC; uc002tbw.6; human.
DR   CTD; 8809; -.
DR   DisGeNET; 8809; -.
DR   GeneCards; IL18R1; -.
DR   HGNC; HGNC:5988; IL18R1.
DR   HPA; ENSG00000115604; Tissue enhanced (lung).
DR   MIM; 604494; gene.
DR   neXtProt; NX_Q13478; -.
DR   OpenTargets; ENSG00000115604; -.
DR   PharmGKB; PA29804; -.
DR   VEuPathDB; HostDB:ENSG00000115604.10; -.
DR   eggNOG; ENOG502QUAC; Eukaryota.
DR   GeneTree; ENSGT01020000230395; -.
DR   HOGENOM; CLU_025552_3_1_1; -.
DR   InParanoid; Q13478; -.
DR   OMA; NFLEFWP; -.
DR   OrthoDB; 985064at2759; -.
DR   PhylomeDB; Q13478; -.
DR   TreeFam; TF325519; -.
DR   PathwayCommons; Q13478; -.
DR   Reactome; R-HSA-9008059; Interleukin-37 signaling.
DR   Reactome; R-HSA-9012546; Interleukin-18 signaling.
DR   SIGNOR; Q13478; -.
DR   BioGRID-ORCS; 8809; 9 hits in 987 CRISPR screens.
DR   GeneWiki; IL18R1; -.
DR   GenomeRNAi; 8809; -.
DR   Pharos; Q13478; Tbio.
DR   PRO; PR:Q13478; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q13478; protein.
DR   Bgee; ENSG00000115604; Expressed in right lung and 146 other tissues.
DR   ExpressionAtlas; Q13478; baseline and differential.
DR   Genevisible; Q13478; HS.
DR   GO; GO:0045092; C:interleukin-18 receptor complex; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0004908; F:interleukin-1 receptor activity; IEA:InterPro.
DR   GO; GO:0042007; F:interleukin-18 binding; IDA:UniProtKB.
DR   GO; GO:0042008; F:interleukin-18 receptor activity; IDA:UniProtKB.
DR   GO; GO:0050135; F:NAD(P)+ nucleosidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0061809; F:NAD+ nucleotidase, cyclic ADP-ribose generating; IEA:UniProtKB-EC.
DR   GO; GO:0038023; F:signaling receptor activity; TAS:ProtInc.
DR   GO; GO:0071345; P:cellular response to cytokine stimulus; TAS:Reactome.
DR   GO; GO:0006955; P:immune response; TAS:ProtInc.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0035655; P:interleukin-18-mediated signaling pathway; IDA:UniProtKB.
DR   GO; GO:0030101; P:natural killer cell activation; IEA:Ensembl.
DR   GO; GO:0120163; P:negative regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:0032729; P:positive regulation of interferon-gamma production; IDA:UniProtKB.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB.
DR   GO; GO:1901224; P:positive regulation of NIK/NF-kappaB signaling; IEA:Ensembl.
DR   GO; GO:2000556; P:positive regulation of T-helper 1 cell cytokine production; IDA:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0045063; P:T-helper 1 cell differentiation; IEA:Ensembl.
DR   Gene3D; 2.60.40.10; -; 3.
DR   Gene3D; 3.40.50.10140; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR015621; IL-1_rcpt_fam.
DR   InterPro; IPR004074; IL-1_rcpt_I/II-typ.
DR   InterPro; IPR000157; TIR_dom.
DR   InterPro; IPR035897; Toll_tir_struct_dom_sf.
DR   PANTHER; PTHR11890; PTHR11890; 1.
DR   Pfam; PF01582; TIR; 1.
DR   PRINTS; PR01536; INTRLKN1R12F.
DR   SMART; SM00409; IG; 3.
DR   SMART; SM00255; TIR; 1.
DR   SUPFAM; SSF48726; SSF48726; 2.
DR   SUPFAM; SSF52200; SSF52200; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS50104; TIR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   Hydrolase; Immunoglobulin domain; Inflammatory response; Membrane; NAD;
KW   Receptor; Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000269|PubMed:9325300"
FT   CHAIN           19..541
FT                   /note="Interleukin-18 receptor 1"
FT                   /id="PRO_0000015448"
FT   TOPO_DOM        22..329
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        330..350
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        351..541
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          33..121
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          133..212
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          220..312
FT                   /note="Ig-like C2-type 3"
FT   DOMAIN          373..520
FT                   /note="TIR"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00204"
FT   ACT_SITE        455
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00204"
FT   CARBOHYD        91
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:25500532,
FT                   ECO:0007744|PDB:3WO3, ECO:0007744|PDB:3WO4"
FT   CARBOHYD        102
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:25500532,
FT                   ECO:0007744|PDB:3WO3, ECO:0007744|PDB:3WO4"
FT   CARBOHYD        150
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:25500532,
FT                   ECO:0007744|PDB:3WO3, ECO:0007744|PDB:3WO4"
FT   CARBOHYD        197
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:25261253,
FT                   ECO:0000269|PubMed:25500532, ECO:0007744|PDB:3WO3,
FT                   ECO:0007744|PDB:3WO4, ECO:0007744|PDB:4R6U"
FT   CARBOHYD        203
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:25261253,
FT                   ECO:0000269|PubMed:25500532, ECO:0007744|PDB:3WO3,
FT                   ECO:0007744|PDB:3WO4, ECO:0007744|PDB:4R6U"
FT   CARBOHYD        236
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:25261253,
FT                   ECO:0000269|PubMed:25500532, ECO:0007744|PDB:3WO3,
FT                   ECO:0007744|PDB:3WO4, ECO:0007744|PDB:4R6U"
FT   CARBOHYD        255
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        297
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:25261253,
FT                   ECO:0000269|PubMed:25500532, ECO:0007744|PDB:3WO3,
FT                   ECO:0007744|PDB:3WO4, ECO:0007744|PDB:4R6U"
FT   DISULFID        22..41
FT                   /evidence="ECO:0000269|PubMed:25261253,
FT                   ECO:0000269|PubMed:25500532, ECO:0007744|PDB:3WO3,
FT                   ECO:0007744|PDB:3WO4, ECO:0007744|PDB:4R6U"
FT   DISULFID        43..81
FT                   /evidence="ECO:0000269|PubMed:25261253,
FT                   ECO:0000269|PubMed:25500532, ECO:0007744|PDB:3WO3,
FT                   ECO:0007744|PDB:3WO4, ECO:0007744|PDB:4R6U"
FT   DISULFID        119..158
FT                   /evidence="ECO:0000269|PubMed:25261253,
FT                   ECO:0000269|PubMed:25500532, ECO:0007744|PDB:3WO3,
FT                   ECO:0007744|PDB:3WO4, ECO:0007744|PDB:4R6U"
FT   DISULFID        140..185
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0000269|PubMed:25261253, ECO:0000269|PubMed:25500532,
FT                   ECO:0007744|PDB:3WO3, ECO:0007744|PDB:3WO4,
FT                   ECO:0007744|PDB:4R6U"
FT   DISULFID        237..298
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0000269|PubMed:25261253, ECO:0000269|PubMed:25500532,
FT                   ECO:0007744|PDB:3WO3, ECO:0007744|PDB:3WO4,
FT                   ECO:0007744|PDB:4R6U"
FT   VARIANT         210
FT                   /note="R -> H (in dbSNP:rs11465635)"
FT                   /id="VAR_053379"
FT   VARIANT         232
FT                   /note="N -> K (in dbSNP:rs11465644)"
FT                   /id="VAR_053380"
FT   VARIANT         310
FT                   /note="S -> N (in dbSNP:rs11465648)"
FT                   /id="VAR_053381"
FT   VARIANT         317
FT                   /note="Missing"
FT                   /evidence="ECO:0000269|PubMed:8626725"
FT                   /id="VAR_014955"
FT   VARIANT         423
FT                   /note="G -> R (in dbSNP:rs12619169)"
FT                   /id="VAR_053382"
FT   MUTAGEN         297
FT                   /note="N->Q: Decreases the affinity for IL18 suggesting
FT                   that the N-linked glycosylation contributes to ligand
FT                   recognition."
FT                   /evidence="ECO:0000269|PubMed:25500532"
FT   STRAND          26..31
FT                   /evidence="ECO:0007744|PDB:4R6U"
FT   STRAND          36..39
FT                   /evidence="ECO:0007744|PDB:4R6U"
FT   TURN            43..47
FT                   /evidence="ECO:0007744|PDB:3WO3"
FT   STRAND          55..59
FT                   /evidence="ECO:0007744|PDB:4R6U"
FT   STRAND          76..79
FT                   /evidence="ECO:0007744|PDB:4R6U"
FT   STRAND          82..87
FT                   /evidence="ECO:0007744|PDB:4R6U"
FT   HELIX           90..92
FT                   /evidence="ECO:0007744|PDB:4R6U"
FT   STRAND          94..100
FT                   /evidence="ECO:0007744|PDB:4R6U"
FT   STRAND          103..112
FT                   /evidence="ECO:0007744|PDB:4R6U"
FT   STRAND          116..120
FT                   /evidence="ECO:0007744|PDB:4R6U"
FT   HELIX           122..124
FT                   /evidence="ECO:0007744|PDB:4R6U"
FT   STRAND          125..131
FT                   /evidence="ECO:0007744|PDB:4R6U"
FT   STRAND          134..139
FT                   /evidence="ECO:0007744|PDB:4R6U"
FT   TURN            143..145
FT                   /evidence="ECO:0007744|PDB:4R6U"
FT   HELIX           146..148
FT                   /evidence="ECO:0007744|PDB:4R6U"
FT   STRAND          149..156
FT                   /evidence="ECO:0007744|PDB:4R6U"
FT   STRAND          166..168
FT                   /evidence="ECO:0007744|PDB:3WO3"
FT   STRAND          170..174
FT                   /evidence="ECO:0007744|PDB:4R6U"
FT   HELIX           177..179
FT                   /evidence="ECO:0007744|PDB:4R6U"
FT   STRAND          181..191
FT                   /evidence="ECO:0007744|PDB:4R6U"
FT   STRAND          194..207
FT                   /evidence="ECO:0007744|PDB:4R6U"
FT   STRAND          216..219
FT                   /evidence="ECO:0007744|PDB:3WO4"
FT   STRAND          221..226
FT                   /evidence="ECO:0007744|PDB:4R6U"
FT   STRAND          233..241
FT                   /evidence="ECO:0007744|PDB:4R6U"
FT   STRAND          246..250
FT                   /evidence="ECO:0007744|PDB:4R6U"
FT   STRAND          261..263
FT                   /evidence="ECO:0007744|PDB:3WO3"
FT   STRAND          266..270
FT                   /evidence="ECO:0007744|PDB:4R6U"
FT   TURN            272..274
FT                   /evidence="ECO:0007744|PDB:3WO4"
FT   STRAND          276..284
FT                   /evidence="ECO:0007744|PDB:4R6U"
FT   TURN            290..292
FT                   /evidence="ECO:0007744|PDB:4R6U"
FT   STRAND          296..302
FT                   /evidence="ECO:0007744|PDB:4R6U"
FT   STRAND          305..314
FT                   /evidence="ECO:0007744|PDB:4R6U"
SQ   SEQUENCE   541 AA;  62304 MW;  7173DB9C7EA71D32 CRC64;
     MNCRELPLTL WVLISVSTAE SCTSRPHITV VEGEPFYLKH CSCSLAHEIE TTTKSWYKSS
     GSQEHVELNP RSSSRIALHD CVLEFWPVEL NDTGSYFFQM KNYTQKWKLN VIRRNKHSCF
     TERQVTSKIV EVKKFFQITC ENSYYQTLVN STSLYKNCKK LLLENNKNPT IKKNAEFEDQ
     GYYSCVHFLH HNGKLFNITK TFNITIVEDR SNIVPVLLGP KLNHVAVELG KNVRLNCSAL
     LNEEDVIYWM FGEENGSDPN IHEEKEMRIM TPEGKWHASK VLRIENIGES NLNVLYNCTV
     ASTGGTDTKS FILVRKADMA DIPGHVFTRG MIIAVLILVA VVCLVTVCVI YRVDLVLFYR
     HLTRRDETLT DGKTYDAFVS YLKECRPENG EEHTFAVEIL PRVLEKHFGY KLCIFERDVV
     PGGAVVDEIH SLIEKSRRLI IVLSKSYMSN EVRYELESGL HEALVERKIK IILIEFTPVT
     DFTFLPQSLK LLKSHRVLKW KADKSLSYNS RFWKNLLYLM PAKTVKPGRD EPEVLPVLSE
     S
//
